Publications

  1. Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, Hopper JL, Apicella C, Southey MC, Stone J, Schmidt MK, Broeks A, Van't Veer LJ, Th Rutgers EJ, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Haeberle L, Ekici AB, Beckman Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum Mol Genet. 2014 Aug 28. [Epub ahead of print]
    View PubMed
  2. Allen SV, Pruthi S, Suman VJ, Hoskin TL, Vachon CM, Ingle JN, Olson JE. Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder. J Diet Suppl. 2014 Aug 28. [Epub ahead of print]
    View PubMed
  3. Fowler EE, Vachon CM, Scott CG, Sellers TA, Heine JJ. Automated Percentage of Breast Density Measurements for Full-field Digital Mammography Applications. Acad Radiol. 2014 Aug; 21(8):958-70.
    View PubMed
  4. Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines. Cancer. 2014 Jul 1; 120(13):2000-5. Epub 2014 Apr 07.
    View PubMed
  5. Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menendez-Rodriguez P, Hardisson D, Mendiola M, Gonzalez-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, Ashworth A, Orr N, Schoemaker M, Ko YD, Brauch H, Hamann U, The Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Hum Mol Genet. 2014 Jun 18.
    View PubMed
  6. Purrington KS, Slettedahl S, Bolla MK, Michailidou K, Czene K, Nevanlinna H, Bojesen SE, Andrulis IL, Cox A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa A, Winqvist R, Brenner H, Lindblom A, Chenevix-Trench G, Benitez J, Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Hum Mol Genet. 2014 Jun 13.
    View PubMed
  7. Pettersson A, Graff RE, Ursin G, Santos Silva ID, McCormack V, Baglietto L, Vachon C, Bakker MF, Giles GG, Chia KS, Czene K, Eriksson L, Hall P, Hartman M, Warren RM, Hislop G, Chiarelli AM, Hopper JL, Krishnan K, Li J, Li Q, Pagano I, Rosner BA, Wong Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2014 May; 106(5). Epub 2014 May 10.
    View PubMed
  8. Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis. 2014 May; 35(5):1012-9. Epub 2013 Dec 09.
    View PubMed
  9. Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP, Zamora MP, Arias-Perez JI, Gonzalez-Neira A, Pita G, Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, Darabi H, Li JM, Anton-Culver H, Neuhausen SL, Ziogas A, Clarke CA, Hopper JL, A large-scale assessment of two-way snp interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium. Hum Mol Genet. 2014 Apr 1; 23(7):1934-46.
  10. Wang AT, Vachon CM, Brandt KR, Ghosh K. Breast density and breast cancer risk: a practical review. Mayo Clin Proc. 2014 Apr; 89(4):548-57.
    View PubMed
  11. Woolcott CG, Conroy SM, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano IS, Byrne C, Maskarinec G. Methods for assessing and representing mammographic density: an analysis of 4 case-control studies. Am J Epidemiol. 2014 Jan 15; 179(2):236-44. Epub 2013 Oct 11.
    View PubMed
  12. Schoeps A, Rudolph A, Seibold P, Dunning AM, Milne RL, Bojesen SE, Swerdlow A, Andrulis I, Brenner H, Behrens S, Orr N, Jones M, Ashworth A, Li J, Cramp H, Connley D, Czene K, Darabi H, Chanock SJ, Lissowska J, Figueroa JD, Knight J, Glendon G, Mulligan Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol. 2014 Jan; 38(1):84-93. Epub 2013 Nov 18.
    View PubMed
  13. Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson M, Klevebring Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun. 2014; 4:4999. Epub 2014 Sep 23.
    View PubMed
  14. Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, Meyer KB, Menendez-Rodriguez P, Hardisson D, Mendiola M, Gonzalez-Neira A, Lindblom A, Margolin S, Swerdlow A, Ashworth A, Orr N, Jones M, Matsuo K, FGF receptor genes and breast cancer susceptibility: Results from the Breast Cancer Association Consortium. Br J Cancer. 2014; 110(4):1088-100.
  15. Nielsen M, Vachon CM, Scott CG, Chernoff K, Karemore G, Karssemeijer N, Lillholm M, Karsdal MA. Mammographic texture resemblance generalizes as an independent risk factor for breast cancer. Breast Cancer Res. 2014; 16(2):R37.
  16. Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't Veer LJ, Hogervorst FB, Muir K, Lophatananon A Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet. 2013 Dec 5; 93(6):1046-60. Epub 2013 Nov 27
    View PubMed
  17. Reese SE, Archer KJ, Therneau TM, Atkinson EJ, Vachon CM, de Andrade M, Kocher JP, Eckel-Passow JE. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis. Bioinformatics. 2013 Nov 15; 29(22):2877-83. Epub 2013 Aug 19.
    View PubMed
  18. Bertrand KA, Tamimi RM, Scott CG, Jensen MR, Pankratz VS, Visscher D, Norman A, Couch F, Shepherd J, Fan B, Chen YY, Ma L, Beck AH, Cummings SR, Kerlikowske K, Vachon CM. Mammographic density and risk of breast cancer by age and tumor characteristics. Breast Cancer Res. 2013 Nov 04; 15(6):R104.
    View PubMed
  19. Greenberg AJ, Cousin M, Kumar S, Ketterling RP, Knudson RA, Larson D, Colby C, Scott C, Vachon CM, Rajkumar SV. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma. Eur J Haematol. 2013 Sep; 91(3):193-5. Epub 2013 Jul 22.
    View PubMed
  20. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013 Aug; 45(8):868-76. Epub 2013 Jun 16.
    View PubMed
  21. Vachon CM, Suman VJ, Brandt KR, Kosel ML, Buzdar AU, Olson JE, Wu FF, Flickinger LM, Ursin G, Elliott CR, Shepherd L, Weinshilboum RM, Goss PE, Ingle JN. Mammographic breast density response to aromatase inhibition. Clin Cancer Res. 2013 Apr 15; 19(8):2144-53. Epub 2013 Mar 06.
    View PubMed
  22. Stevens KN, Vachon CM, Couch FJ. Genetic susceptibility to triple-negative breast cancer. Cancer Res. 2013 Apr 1; 73(7):2025-30. Epub 2013 Mar 27.
    View PubMed
  23. Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, Breast and Ovarian Cancer Susceptibility Collaboration, Fletcher O, Peto J, Gibson L Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet. 2013 Apr; 45(4):353-61, 361e1-2.
    View PubMed
  24. Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, Karevan R, Woods N, Johnston RL, French JD, Chen X, Weischer M, Nielsen SF, Maranian MJ, Gh Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013 Apr; 45(4):371-84, 384e1-2.
    View PubMed
  25. Slager SL, Achenbach SJ, Asmann YW, Camp NJ, Rabe KG, Goldin LR, Call TG, Shanafelt TD, Kay NE, Cunningham JM, Wang AH, Weinberg JB, Norman AD, Link BK, Leis JF, Vachon CM, Lanasa MC, Caporaso NE, Novak AJ, Cerhan JR. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):461-6. Epub 2013 Jan 10.
    View PubMed
  26. Greenberg AJ, Lee AM, Serie DJ, McDonnell SK, Cerhan JR, Liebow M, Larson DR, Colby CL, Norman AD, Kyle RA, Kumar S, Rajkumar SV, Diasio RB, Slager SL, Vachon CM. Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma. Leukemia. 2013 Feb; 27(2):515-6. Epub 2012 Aug 16
    View PubMed
  27. Vachon CM, Fowler EE, Tiffenberg G, Scott CG, Pankratz VS, Sellers TA, Heine JJ. Comparison of percent density from raw and processed full-field digital mammography data. Breast Cancer Res. 2013 Jan 04; 15(1):R1.
    View PubMed
  28. Rudolph A, Hein R, Lindstrom S, Beckmann L, Behrens S, Liu J, Aschard H, Bolla MK, Wang J, Truong T, Cordina-Duverger E, Menegaux F, Bruning T, Harth V, Lo WY, Severi G, Baglietto L, Southey M, Chanock SJ, Lissowska J, Figueroa JD, Eriksson M, Humpreys Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: A genome-wide interaction study. Endocr Relat Cancer. 2013; 20(6):875-87.
  29. Vachon CM, Ghosh K, Brandt KR. Mammographic density: Potential as a risk factor and surrogate marker in the clinical setting. Current Breast Cancer Reports. 2013; 5(3):183-93.
  30. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Haberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013; 9(3):e1003284. Epub 2013 Mar 27.
    View PubMed
  31. Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, Michailidou K, Stram DO, Beckmann L, Rhie SK, Ambrosone CB, Aittomaki K, Amiano P, Apicella C, Australian Breast Cancer Tissue Bank Investigators, Baglietto L, Bandera EV, Beckmann MW, Berg A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet. 2012 Dec 15; 21(24):5373-84. Epub 2012 Sep 13.
    View PubMed
  32. Slager SL, Camp NJ, Conde L, Shanafelt TD, Achenbach SJ, Rabe KG, Kay NE, Novak AJ, Call TG, Bracci PM, Sille FM, Sanchez S, Akers NK, Cunningham JM, Serie DJ, McDonnell SK, Leis JF, Wang AH, Weinberg JB, Glenn M, Link B, Vachon CM, Lanasa MC, Skibola Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol. 2012 Dec; 159(5):572-6. Epub 2012 Oct 01.
    View PubMed
  33. Olson JE, Sellers TA, Scott CG, Schueler BA, Brandt KR, Serie DJ, Jensen MR, Wu FF, Morton MJ, Heine JJ, Couch FJ, Pankratz VS, Vachon CM. The influence of mammogram acquisition on the mammographic density and breast cancer association in the mayo mammography health study cohort. Breast Cancer Res. 2012 Nov 15; 14(6):R147.
    View PubMed
  34. Conroy SM, Koga K, Woolcott CG, Dahl T, Byrne C, Nagata C, Ursin G, Yaffe MJ, Vachon CM, Maskarinec G. Higher alcohol intake may modify the association between mammographic density and breast cancer: an analysis of three case-control studies. Cancer Epidemiol. 2012 Oct; 36(5):458-60. Epub 2012 Jul 10.
    View PubMed
  35. Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, Lophatananon A, Chaiwerawattana A, Wiangnon S, Fasching PA, Beckmann MW, Ekici AB, 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2012 Oct; 21(10):1783-91. Epub 2012 Aug 02.
    View PubMed
  36. Slager SL, Skibola CF, Di Bernardo MC, Conde L, Broderick P, McDonnell SK, Goldin LR, Croft N, Holroyd A, Harris S, Riby J, Serie DJ, Kay NE, Call TG, Bracci PM, Halperin E, Lanasa MC, Cunningham JM, Leis JF, Morrison VA, Spector LG, Vachon CM, Shanafelt Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood. 2012 Jul 26; 120(4):843-6. Epub 2012 Jun 13
    View PubMed
  37. Stevens KN, Lindstrom S, Scott CG, Thompson D, Sellers TA, Wang X, Wang A, Atkinson E, Rider DN, Eckel-Passow JE, Varghese JS, Audley T, Brown J, Leyland J, Luben RN, Warren RM, Loos RJ, Wareham NJ, Li J, Hall P, Liu J, Eriksson L, Czene K, Olson JE, Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet. 2012 Jul 15; 21(14):3299-305. Epub 2012 Apr 24.
    View PubMed
  38. Heine JJ, Scott CG, Sellers TA, Brandt KR, Serie DJ, Wu FF, Morton MJ, Schueler BA, Couch FJ, Olson JE, Pankratz VS, Vachon CM. A novel automated mammographic density measure and breast cancer risk. J Natl Cancer Inst. 2012 Jul 03; 104(13):1028-37.
    View PubMed
  39. Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernandez-Navarro P, Gonzalez-Neira A, Benitez J, van Gils CH, Lokate M, Onland-Moret NC, Peeters PH, Brown Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2012 Jul; 21(7):1156-66. Epub 2012 Mar 27.
    View PubMed
  40. Greenberg AJ, Rajkumar SV, Vachon CM. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood. 2012 Jun 7; 119(23):5359-66. Epub 2012 Feb 21.
    View PubMed
  41. Colon-Otero G, Albertie M, Lesperance M, Weis JA, Coles A, Smith N, Mills L, Woodward T, Aspitia AM, Vishnu P, Willis F, Isley A, Fonseca R, Vachon C, Rajkumar SV. A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. J Cancer Educ. 2012 Jun; 27(2):294-8.
    View PubMed
  42. Greenberg AJ, Rajkumar SV, Larson DR, Dispenzieri A, Therneau TM, Colby CL, Phelps TK, Kumar SK, Katzmann JA, Kyle RA, Slager SL, Vachon CM. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma. Br J Haematol. 2012 May; 157(4):472-5.
    View PubMed
  43. Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, Shane Pankratz V, Radisky DC, Hartmann LC. Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat. 2012 May; 133(1):169-77. Epub 2011 Sep 1
    View PubMed
  44. Conroy SM, Woolcott CG, Koga KR, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G. Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies. Int J Cancer. 2012 Apr 15; 130(8):1915-24. Epub 2011 Sep 17.
    View PubMed
  45. Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomaki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, Nickels S, Brauch H, GENICA Network, Ko YD, Fischer HP, Schmutzler 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res. 2012 Apr 1; 72(7):1795-803. Epub 2012 Feb 13.
    View PubMed
  46. Greenberg AJ, Vachon CM, Rajkumar SV. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012 Apr; 26(4):609-14. Epub 2011 Dec 23.
    View PubMed
  47. Woolcott CG, Koga K, Conroy SM, Byrne C, Nagata C, Ursin G, Vachon CM, Yaffe MJ, Pagano I, Maskarinec G. Mammographic density, parity and age at first birth, and risk of breast cancer: an analysis of four case-control studies. Breast Cancer Res Treat. 2012 Apr; 132(3):1163-71. Epub 2012 Jan 06.
    View PubMed
  48. Varghese JS, Thompson DJ, Michailidou K, Lindstrom S, Turnbull C, Brown J, Leyland J, Warren RM, Luben RN, Loos RJ, Wareham NJ, Rommens J, Paterson AD, Martin LJ, Vachon CM, Scott CG, Atkinson EJ, Couch FJ, Apicella C, Southey MC, Stone J, Li J, Eriksson Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res. 2012 Mar 15; 72(6):1478-84. Epub 2012 Jan 19
    View PubMed
  49. Rausch SM, Millay S, Scott C, Pruthi S, Clark MM, Patten C, Stan D, Sellers T, Vachon C. Health behaviors among cancer survivors receiving screening mammography. Am J Clin Oncol. 2012 Feb; 35(1):22-31.
    View PubMed
  50. Ghosh K, Brandt KR, Reynolds C, Scott CG, Pankratz VS, Riehle DL, Lingle WL, Odogwu T, Radisky DC, Visscher DW, Ingle JN, Hartmann LC, Vachon CM. Tissue composition of mammographically dense and non-dense breast tissue. Breast Cancer Res Treat. 2012 Jan; 131(1):267-75. Epub 2011 Aug 30.
    View PubMed
  51. Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo KY, Noh DY, Ahn SH, Dork T, Schurmann P, Karstens JH, Hillemanns P, Couch FJ, Olson J, Vachon C, Wang X, Cox A, Brock I, Elliott Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. PLoS One. 2012; 7(6):e35706. Epub 2012 Jun 29
    View PubMed
  52. Vachon CM, Li J, Scott CG, Hall P, Czene K, Wang X, Liu J, Fredericksen ZS, Rider DN, Wu FF, Olson JE, Cunningham JM, Stevens KN, Sellers TA, Pankratz SV, Couch FJ. No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density. Breast Cancer Res. 2012; 14(1):R7. Epub 2012 Jan 07.
    View PubMed
  53. Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't, Tollenaar RA, Fasching PA, Beckmann MW, Hein A, Ekici AB, Johnson N, Peto J, dos Santos, Gibson L, Sawyer E, Tomli Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Br J Cancer. 2011 Dec 6; 105(12):1934-9. Epub 2011 Oct 27
    View PubMed
  54. Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC, Wang X, Ademuyiwa F, Ahmed S, Ambrosone CB, Baglietto L, Balleine R, Bandera EV, Beckmann MW, Berg CD, Bernstein L, Blomqvist C, Blot WJ, Brauch H, Buring JE, Carey LA, Carpenter JE, Chang- A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet. 2011 Dec; 43(12):1210-4. Epub 2011 Oct 30
    View PubMed
  55. Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, Fasching PA, Miron P, Eccles D, Carpenter JE, Godwin AK, Ambrosone C, Winqvist R, Brauch H, GENICA consortium, Schmidt MK, Cox A, Cross SS, Sawyer E, Hartmann A, Beckmann MW, Schulz-Wendtland Common breast cancer susceptibility loci are associated with triple-negative breast cancer. Cancer Res. 2011 Oct 1; 71(19):6240-9. Epub 2011 Aug 15.
    View PubMed
  56. Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, Kay NE, Hanson CA, Rabe KG, Achenbach SJ, Goldin LR, Camp NJ, Goodman BK, Vachon CM, Spector LG, Rassenti LZ, Leis JF, Gockerman JP, Strom SS, Call TG, Glenn M, Cerhan JR, Levesque MC, Weinberg Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia. 2011 Sep; 25(9):1459-66. Epub 2011 May 27.
    View PubMed
  57. Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Cerhan J, Vachon CM, Olson JE, Couch FJ. Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):617-22. Epub 2011 May 24.
    View PubMed
  58. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 3; 103(15):1179-89. Epub 2011 Jul 27.
    View PubMed
  59. Nielsen M, Karemore G, Loog M, Raundahl J, Karssemeijer N, Otten JD, Karsdal MA, Vachon CM, Christiansen C. A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer. Cancer Epidemiol. 2011 Aug; 35(4):381-7. Epub 2010 Dec 10.
    View PubMed
  60. Lindstrom S, Vachon CM, Li J, Varghese J, Thompson D, Warren R, Brown J, Leyland J, Audley T, Wareham NJ, Loos RJ, Paterson AD, Rommens J, Waggott D, Martin LJ, Scott CG, Pankratz VS, Hankinson SE, Hazra A, Hunter DJ, Hopper JL, Southey MC, Chanock SJ, Si Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet. 2011 Mar; 43(3):185-7. Epub 2011 Jan 30
    View PubMed
  61. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti LZ, Leis JF, Camp NJ, Glenn M, Kay NE, Cunningham JM, Hanson CA, Marti GE, Weinberg JB, Morrison VA, Link BK, Call TG, Caporaso NE, Cerhan JR. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2011 Feb 10; 117(6):1911-6. Epub 2010 Dec 03.
    View PubMed
  62. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, Flesch-Janys D, Heinz J, Sinn P, Vrieling A, Heikkinen T, Aittomaki K, Heikkila P, Blomqvist Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011 Feb 2; 103(3):250-63. Epub 2010 Dec 29.
    View PubMed
  63. Bardia A, Olson JE, Vachon CM, Lazovich D, Vierkant RA, Wang AH, Limburg PJ, Anderson KE, Cerhan JR. Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):149-55. Epub 2010 Jul 29.
    View PubMed
  64. Vachon CM, Sasano H, Ghosh K, Brandt KR, Watson DA, Reynolds C, Lingle WL, Goss PE, Li R, Aiyar SE, Scott CG, Pankratz VS, Santen RJ, Ingle JN. Aromatase immunoreactivity is increased in mammographically dense regions of the breast. Breast Cancer Res Treat. 2011 Jan; 125(1):243-52. Epub 2010 Jun 05.
    View PubMed
  65. Olson JE, Wang X, Pankratz VS, Fredericksen ZS, Vachon CM, Vierkant RA, Cerhan JR, Couch FJ. Centrosome-related genes, genetic variation, and risk of breast cancer. Breast Cancer Res Treat. 2011 Jan; 125(1):221-8. Epub 2010 May 28.
    View PubMed
  66. de Andrade M, Atkinson EJ, Bamlet WR, Matsumoto ME, Maharjan S, Slager SL, Vachon CM, Cunningham JM, Kardia SL. Evaluating the influence of quality control decisions and software algorithms on SNP calling for the affymetrix 6.0 SNP array platform. Hum Hered. 2011; 71(4):221-33. Epub 2011 Jul 02.
    View PubMed
  67. Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Australian Ovarian Cancer Study Group, Dale LC, Lambrechts D, Amant F, Despierre E, Vergote I, Gayther SA, Gentry-Maharaj A, Menon U, Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. PLoS One. 2011; 6(5):e19642. Epub 2011 May 27.
    View PubMed
  68. Ghosh K, Vachon CM, Pankratz VS, Vierkant RA, Anderson SS, Brandt KR, Visscher DW, Reynolds C, Frost MH, Hartmann LC. Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst. 2010 Nov 17; 102(22):1716-23. Epub 2010 Oct 29.
    View PubMed
  69. Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Algood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol. 2010 Oct; 151(2):152-8. Epub 2010 Aug 25.
    View PubMed
  70. Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, Cook LS, Gronwald J, Garcia-Closas M, Gore ME, Campbell I, A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010 Oct; 42(10):874-9. Epub 2010 Sep 19.
    View PubMed
  71. Kerlikowske K, Cook AJ, Buist DS, Cummings SR, Vachon C, Vacek P, Miglioretti DL. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol. 2010 Aug 20; 28(24):3830-7. Epub 2010 Jul 19.
    View PubMed
  72. Gierach GL, Loud JT, Chow CK, Prindiville SA, Eng-Wong J, Soballe PW, Giambartolomei C, Mai PL, Galbo CE, Nichols K, Calzone KA, Vachon C, Gail MH, Greene MH. Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat. 2010 Aug; 123(1):245-55. Epub 2010 Feb 04.
    View PubMed
  73. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010 Aug; 42(8):661-4. Epub 2010 Jul 18.
    View PubMed
  74. Ghosh K, Hartmann LC, Reynolds C, Visscher DW, Brandt KR, Vierkant RA, Scott CG, Radisky DC, Sellers TA, Pankratz VS, Vachon CM. Association between mammographic density and age-related lobular involution of the breast. J Clin Oncol. 2010 May 1; 28(13):2207-12. Epub 2010 Mar 29.
    View PubMed
  75. Slager SL, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Kay NE, Vachon CM, Glenn M, Weinberg JB, Rabe KG, Cunningham JM, Achenbach SJ, Hanson CA, Marti GE, Call TG, Caporaso NE, Cerhan JR. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2010 Apr; 19(4):1098-102. Epub 2010 Mar 23.
    View PubMed
  76. Mathis KL, Hoskin TL, Boughey JC, Crownhart BS, Brandt KR, Vachon CM, Grant CS, Degnim AC. Palpable presentation of breast cancer persists in the era of screening mammography. J Am Coll Surg. 2010 Mar; 210(3):314-8.
    View PubMed
  77. Li JM, Eriksson L, Humphreys K, Czene K, Liu JJ, Tamimi RM, Lindstrom S, Hunter DJ, Vachon CM, Couch FJ, Scott CG, Lagiou P, Hall P. Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer. Breast Cancer Res. 2010; 12(2).
    View PubMed
  78. Kelemen LE, Atkinson EJ, de Andrade M, Pankratz VS, Cunningham JM, Wang A, Hilker CA, Couch FJ, Sellers TA, Vachon CM. Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population. BMC Med Genet. 2010; 11:156. Epub 2010 Nov 09.
    View PubMed
  79. Ghosh K, Vachon CM. Mammographic breast density, endocrine therapies, and breast cancer risk. Sexuality, Reproduction and Menopause. 2010; 8(1):34-9.
  80. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC. Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol. 2009 Dec 10; 27(35):5893-8. Epub 2009 Oct 05.
    View PubMed
  81. Vierkant RA, Hartmann LC, Pankratz VS, Anderson SS, Radisky D, Frost MH, Vachon CM, Ghosh K, Distad TJ, Degnim AC, Reynolds CA. Lobular involution: localized phenomenon or field effect? Breast Cancer Res Treat. 2009 Sep; 117(1):193-6. Epub 2008 Jul 01.
    View PubMed
  82. Vachon CM, Kyle RA, Therneau TM, Foreman BJ, Larson DR, Colby CL, Phelps TK, Dispenzieri A, Kumar SK, Katzmann JA, Rajkumar SV. Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood. 2009 Jul 23; 114(4):785-90. Epub 2009 Jan 29.
    View PubMed
  83. Sinicrope PS, Patten CA, Bonnema SM, Almquist JR, Smith CM, Beebe TJ, Jacobsen SJ, Vachon CM. Healthy women's motivators and barriers to participation in a breast cancer cohort study: a qualitative study. Ann Epidemiol. 2009 Jul; 19(7):484-93. Epub 2009 Mar 09.
    View PubMed
  84. Nevala WK, Vachon CM, Leontovich AA, Scott CG, Thompson MA, Markovic SN, Melanoma Study Group of the Mayo Clinic Cancer Center. Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma. Clin Cancer Res. 2009 Mar 15; 15(6):1931-9. Epub 2009 Feb 24
    View PubMed
  85. Manduca A, Carston MJ, Heine JJ, Scott CG, Pankratz VS, Brandt KR, Sellers TA, Vachon CM, Cerhan JR. Texture features from mammographic images and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Mar; 18(3):837-45. Epub 2009 Mar 03.
    View PubMed
  86. Fernandez-Perez ER, Sprung J, Afessa B, Warner DO, Vachon CM, Schroeder DR, Brown DR, Hubmayr RD, Gajic O. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study. Thorax. 2009 Feb; 64(2):121-7. Epub 2008 Nov 06.
    View PubMed
  87. Sinicrope PS, Patten CA, Clark LP, Brockman TA, Rock EE, Frost MH, Petersen LR, Vierkant RA, Vachon CM, Fredericksen ZS, Janney CA, Sellers TA, Cerhan JR. Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study. Psychooncology. 2009 Feb; 18(2):169-78.
    View PubMed
  88. Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, Vogel V, Shepherd J, Vachon C, Smith-Bindman R, Kerlikowske K. Prevention of breast cancer in postmenopausal women: systematic reviews of approaches to estimating and reducing risk. JNCI. 2009; 101:384-98.
  89. Pankratz VS, Hartmann LC, Degnim AC, Vierkant RA, Ghosh K, Vachon CM, Frost MH, Maloney SD, Reynolds C, Boughey JC. Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol. 2008 Nov 20; 26(33):5374-9. Epub 2008 Oct 14.
    View PubMed
  90. Heine JJ, Carston MJ, Scott CG, Brandt KR, Wu FF, Pankratz VS, Sellers TA, Vachon CM. An automated approach for estimation of breast density. Cancer Epidemiol Biomarkers Prev. 2008 Nov; 17(11):3090-7.
    View PubMed
  91. Taranova AG, Maldonado D 3rd, Vachon CM, Jacobsen EA, Abdala-Valencia H, McGarry MP, Ochkur SI, Protheroe CA, Doyle A, Grant CS, Cook-Mills J, Birnbaumer L, Lee NA, Lee JJ. Allergic pulmonary inflammation promotes the recruitment of circulating tumor cells to the lung. Cancer Res. 2008 Oct 15; 68(20):8582-9.
    View PubMed
  92. Kelemen LE, Sellers TA, Vachon CM. Can genes for mammographic density inform cancer aetiology? Nature Rev Cancer. 2008 Oct; 8(10):812-23.
    View PubMed
  93. Wang X, Goode EL, Fredericksen ZS, Vierkant RA, Pankratz VS, Liu-Mares W, Rider DN, Vachon CM, Cerhan JR, Olson JE, Couch FJ. Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Aug; 17(8):2101-8.
    View PubMed
  94. Sekulic A, Haluska P Jr, Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN, Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc. 2008 Jul; 83(7):825-46.
    View PubMed
  95. Sinicrope PS, Brockman TA, Patten CA, Frost MH, Vierkant RA, Petersen LR, Rock E, Clark LP, Vachon CM, Fredericksen ZS, Sellers TA, Cerhan JR. Factors associated with breast cancer prevention communication between mothers and daughters. J Womens Health (Larchmt). 2008 Jul-Aug; 17(6):1017-23.
    View PubMed
  96. Tseng M, Vierkant RA, Kushi LH, Sellers TA, Vachon CM. Dietary patterns and breast density in the Minnesota Breast Cancer Family Study. Cancer Causes Control. 2008 Jun; 19(5):481-9. Epub 2008 Jan 17.
    View PubMed
  97. Kelemen LE, Pankratz VS, Sellers TA, Brandt KR, Wang A, Janney C, Fredericksen ZS, Cerhan JR, Vachon CM. Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study. Am J Epidemiol. 2008 May 1; 167(9):1027-36. Epub 2008 Apr 02.
    View PubMed
  98. Ghosh K, Brandt KR, Sellers TA, Reynolds C, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Vachon CM. Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):872-9.
    View PubMed
  99. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, Bojesen SE, Nordestgaard BG, Axelsson CK, Arias JI, Milne RL, Ribas G, Gonzalez-Neira A, Benitez J, Zamora P, Brauch H, Justenhoven C, Hamann U, Ko YD, Bruening T, Haas S, Dork T, Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet. 2008 Apr; 4(4):e1000054. Epub 2008 Apr 25
    View PubMed
  100. Berg JC, Visscher DW, Vierkant RA, Pankratz VS, Maloney SD, Lewis JT, Frost MH, Ghosh K, Degnim AC, Brandt KR, Vachon CM, Reynolds CA, Hartmann LC. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat. 2008 Mar; 108(2):167-74. Epub 2007 May 22.
    View PubMed
  101. Bardia A, Vachon CM, Olson JE, Vierkant RA, Wang AH, Hartmann LC, Sellers TA, Cerhan JR. Relative weight at age 12 and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):374-8. Epub 2008 Feb 04.
    View PubMed
  102. Kelemen LE, Couch FJ, Ahmed S, Dunning AM, Pharoah PD, Easton DF, Fredericksen ZS, Vierkant RA, Pankratz VS, Goode EL, Scott CG, Rider DN, Wang X, Cerhan JR, Vachon CM. Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies. Breast Cancer Res. 2008; 10(6):R98. Epub 2008 Nov 26.
    View PubMed
  103. Tseng M, Sellers TA, Vierkant RA, Kushi LH, Vachon CM. Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study. Nutr Cancer. 2008; 60(6):703-9.
    View PubMed
  104. Slager SL, Kay NE, Fredericksen ZS, Wang AH, Liebow M, Cunningham JM, Vachon CM, Call TG, Cerhan JR. Susceptibility genes and B-chronic lymphocytic leukaemia. Br J Haematol. 2007 Dec; 139(5):762-71.
    View PubMed
  105. Vachon CM, Sellers TA, Carlson EE, Cunningham JM, Hilker CA, Smalley RL, Schaid DJ, Kelemen LE, Couch FJ, Pankratz VS. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res. 2007 Sep 1; 67(17):8412-8.
    View PubMed
  106. Sellers TA, Vachon CM, Pankratz VS, Janney CA, Fredericksen Z, Brandt KR, Huang Y, Couch FJ, Kushi LH, Cerhan JR. Association of childhood and adolescent anthropometric factors, physical activity, and diet with adult mammographic breast density. Am J Epidemiol. 2007 Aug 15; 166(4):456-64. Epub 2007 Jun 04.
    View PubMed
  107. Bardia A, Ebbert JO, Vierkant RA, Limburg PJ, Anderson K, Wang AH, Olson JE, Vachon CM, Cerhan JR. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality. J Natl Cancer Inst. 2007 Jun 6; 99(11):881-9.
    View PubMed
  108. Sellers TA, Jensen LE, Vierkant RA, Fredericksen ZS, Brandt KR, Giuliano AR, Pankratz VS, Cerhan JR, Vachon CM. Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control. 2007 Jun; 18(5):505-15.
    View PubMed
  109. Vachon CM, Pankratz VS, Scott CG, Maloney SD, Ghosh K, Brandt KR, Milanese T, Carston MJ, Sellers TA. Longitudinal trends in mammographic percent density and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 May; 16(5):921-8.
    View PubMed
  110. Olson JE, Ingle JN, Ma CX, Pelleymounter LL, Schaid DJ, Pankratz VS, Vierkant RA, Fredericksen ZS, Wu Y, Couch FJ, Vachon CM, Sellers TA, Weinshilboum RM. A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches. Breast Cancer Res Treat. 2007 Apr; 102(2):237-47. Epub 2006 Sep 27.
    View PubMed
  111. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc. 2007 Apr; 82(4):490-513.
    View PubMed
  112. Vachon CM, Ingle JN, Suman VJ, Scott CG, Gottardt H, Olson JE, Goss PE. Pilot study of the impact of letrozole vs. placebo on breast density in women completing 5 years of tamoxifen. Breast. 2007 Apr; 16(2):204-10. Epub 2006 Dec 04.
    View PubMed
  113. Olson JE, Ma CX, Pelleymounter LL, Schaid DJ, Pankratz VS, Vierkant RA, Fredericksen ZS, Ingle JN, Wu Y, Couch F, Sellers TA, Weinshilboum RM, Vachon CM. A comprehensive examination of CYP19 variation and breast density. Cancer Epidemiol Biomarkers Prev. 2007 Mar; 16(3):623-5.
    View PubMed
  114. Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET, Melanoma Study Group of the Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007 Mar; 82(3):364-80.
    View PubMed
  115. Vachon CM, Brandt KR, Ghosh K, Scott CG, Maloney SD, Carston MJ, Pankratz VS, Sellers TA. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):43-9.
    View PubMed
  116. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res. 2007; 9(6):217.
    View PubMed
  117. Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status. Arch Intern Med. 2006 Dec 11-25; 166(22):2478-83.
    View PubMed
  118. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ 3rd, Goode EL, Visscher DW. Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst. 2006 Nov 15; 98(22):1600-7.
    View PubMed
  119. Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev. 2006 Oct; 15(10):1988-92.
    View PubMed
  120. Haakenson CP, Vickers KS, Cha SS, Vachon CM, Thielen JM, Kircher KJ, Pruthi S. Efficacy of a simple, low-cost educational intervention in improving knowledge about risks and benefits of screening mammography. Mayo Clin Proc. 2006 Jun; 81(6):783-91.
    View PubMed
  121. Vachon CM, Sellers TA, Janney CA, Brandt KR, Carlson EE, Pankratz VS, Wu FF, Therneau TM, Cerhan JR. Alcohol intake in adolescence and mammographic density. Int J Cancer. 2005 Dec 10; 117(5):837-41.
    View PubMed
  122. Olson JE, Vachon CM, Vierkant RA, Sweeney C, Limburg PJ, Cerhan JR, Sellers TA. Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer. Mayo Clin Proc. 2005 Nov; 80(11):1423-8.
    View PubMed
  123. Madlensky L, Vierkant RA, Vachon CM, Pankratz VS, Cerhan JR, Vadaparampil ST, Sellers TA. Preventive health behaviors and familial breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Oct; 14(10):2340-5.
    View PubMed
  124. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, Roenigk RK. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005 Aug 10; 294(6):681-90.
    View PubMed
  125. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ 3rd, Visscher DW. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005 Jul 21; 353(3):229-37.
    View PubMed
  126. Cerhan JR, Sellers TA, Janney CA, Pankratz VS, Brandt KR, Vachon CM. Prenatal and perinatal correlates of adult mammographic breast density. Cancer Epidemiol Biomarkers Prev. 2005 Jun; 14(6):1502-8.
    View PubMed
  127. Vachon CM, Habermann TM, Kurtin PJ, Cerhan JR. Clinical characteristics of familial vs. sporadic non-hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000). Leuk Lymphoma. 2004 May; 45(5):929-35.
    View PubMed
  128. Sellers TA, Grabrick DM, Vierkant RA, Harnack L, Olson JE, Vachon CM, Cerhan JR. Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? Cancer Causes Control. 2004 Mar; 15(2):113-20.
    View PubMed
  129. Cerhan JR, Grabrick DM, Vierkant RA, Janney CA, Vachon CM, Olson JE, Kushi LH, Sellers TA. Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA). Cancer Causes & Control. 2004 Feb; 15(1):1-9.
    View PubMed
  130. Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer. 2003 Sep 20; 106(5):784-8.
    View PubMed
  131. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, Sellers TA. Lung cancer risk reduction after smoking cessation: Observations from a prospective cohort of women. J Clin Oncol. 2003 Mar 1; 21(5):921-6.
    View PubMed
  132. Yang P, Cerhan JR, Vierkant RA, Olson JE, Vachon CM, Limburg PJ, Parker AS, Anderson KE, Sellers TA. Adenocarcinoma of the lung is strongly associated with cigarette smoking: Further evidence from a prospective study of women. Am J Epidemiol. 2002 Dec 15; 156(12):1114-22.
    View PubMed
  133. Vachon CM, Sellers TA, Vierkant RA, Wu FF, Brandt KR. Case-control study of increased mammographic breast density response to hormone replacement therapy. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1382-8.
    View PubMed
  134. Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2002 Nov; 11(11):1466-71.
    View PubMed
  135. Sellers TA, Vierkant RA, Cerhan JR, Gapstur SM, Vachon CM, Olson JE, Pankratz VS, Kushi LH, Folsom AR. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1104-7.
    View PubMed
  136. Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: A prospective study. Am J Epidemiol. 2002 Sep 15; 156(6):527-35.
    View PubMed
  137. Olson JE, Cerhan JR, Janney CA, Anderson KE, Vachon CM, Sellers TA. Postmenopausal cancer risk after self-reported endometriosis diagnosis in the Iowa Women's Health Study. Cancer. 2002 Mar 1; 94(5):1612-8.
    View PubMed
  138. Cerhan JR, Habermann TM, Vachon CM, Putnam SD, Zheng W, Potter JD, Folsom AR. Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States). Cancer Causes Control. 2002 Mar; 13(2):131-6.
    View PubMed
  139. Vachon CM, Mink PJ, Janney CA, Sellers TA, Cerhan JR, Hartmann L, Folsom AR. Association of parity and ovarian cancer risk by family history of breast or ovarian cancer in a population-based study of postmenopausal women. Epidemiology. 2002 Jan; 13(1):66-71.
    View PubMed
  140. Sellers TA, Alberts SR, Vierkant RA, Grabrick DM, Cerhan JR, Vachon CM, Olson JE, Kushi LH, Potter JD. High folate intakes and breast cancer survival in a prospective cohort study. Nutr and Cancer. 2002; 44:139-44.
  141. Vachon CM, Cerhan JR, Vierkant RA, Sellers TA. Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study. Cancer. 2001 Jul 15; 92(2):240-8.
    View PubMed
  142. Sellers TA, Kushi LH, Cerhan JR, Vierkant RA, Gapstur SM, Vachon CM, Olson JE, Therneau TM, Folsom AR. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul; 12(4):420-8.
    View PubMed
  143. Olson JE, Atwood LD, Grabrick DM, Vachon CM, Sellers TA. Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Family Study. Genet Epidemiol. 2001 May; 20(4):458-78.
    View PubMed
  144. Couch FJ, Cerhan JR, Vierkant RA, Grabrick DM, Therneau TM, Pankratz VS, Hartmann LC, Olson JE, Vachon CM, Sellers TA. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):327-32.
    View PubMed
  145. Grabrick DM, Hartmann LC, Cerhan JR, Vierkant RA, Therneau TM, Vachon CM, Olson JE, Couch FJ, Anderson KE, Pankratz VS, Sellers TA. Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer. JAMA. 2000 Oct 11; 284(14):1791-8.
    View PubMed
  146. Vachon CM, Kuni CC, Anderson K, Anderson VE, Sellers TA. Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). Cancer Causes Control. 2000 Aug; 11(7):653-62.
    View PubMed
  147. Hangiandreou NJ, Mount CJ, Brandt KR, Quam JP, Manduca A, Vachon CM, Sellers TA. An investigation of the effects of mammographic acquisition parameters on a semiautomated quantitative measure of breast cancer risk. J Digit Imaging. 2000 May; 13(2 Suppl 1):186-8.
    View PubMed
  148. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000 Feb; 9(2):151-60.
    View PubMed
  149. Sellers TA, King RA, Cerhan JR, Chen PL, Grabrick DM, Kushi LH, Oetting WS, Vierkant RA, Vachon CM, Couch FJ, Therneau TM, Olson JE, Pankratz VS, Hartmann LC, Anderson VE. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1051-7.
    View PubMed
  150. Paterson AD, Naimark DM, Huang J, Vachon C, Petronis A, King RA, Anderson VE, Sellers TA. Genetic anticipation and breast cancer: a prospective follow-up study. Breast Cancer Res Treat. 1999 May; 55(1):21-8.
    View PubMed
  151. Vachon CM, Sellers TA, Kushi LH, Folsom AR. Familial correlation of dietary intakes among postmenopausal women. Genet Epidemiol. 1998; 15:553-63.
    View PubMed
  152. Pankow JS, Vachon CM, Kuni CC, King RA, Arnett DK, Grabrick DM, Rich SS, Anderson VE, Sellers TA. Genetic analysis of mammographic breast density in adult women: evidence of a gene effect. J Natl Cancer Inst. 1997 Apr 16; 89(8):549-56.
    View PubMed
  153. Seybolt LM, Vachon C, Potter K, Zheng W, Kushi LH, McGovern PG, Sellers TA. Evaluation of potential sources of bias in a genetic epidemiologic study of breast cancer. Genet Epidemiol. 1997; 14(1):85-95.
    View PubMed
  154. Ciske DJ, Rich SS, King RA, Anderson VE, Bartow S, Vachon C, McGovern PG, Kushi LH, Zheng W, Sellers TA. Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models. Genet Epidemiol. 1996; 13(4):317-28.
    View PubMed
  155. Thompson JA, Wiesner GL, Sellers TA, Vachon C, Ahrens M, Potter JD, Sumpmann M, Kersey J. Genetic services for familial cancer patients: a survey of National Cancer Institute cancer centers. J Natl Cancer Inst. 1995 Oct 4; 87(19):1446-55.
    View PubMed